Mitsubishi UFJ Asset Management
NPCE icon

Mitsubishi UFJ Asset Management’s Neuropace NPCE Stock Holding History

Mitsubishi UFJ Asset Management’s Portfolio NPCE Stock Details NPCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$157K Buy
9,890
+2,100
+27% +$33.8K ﹤0.01% 1049
2026
Q1 		$102K Buy
7,790
+132
+2% +$1.98K ﹤0.01% 1039
2025
Q4 		$116K Sell
7,658
-7,212
-49% -$96.4K ﹤0.01% 1052
2025
Q3 		$153K Sell
14,870
-632
-4% -$5.96K ﹤0.01% 1012
2025
Q2 		$173K Buy
+15,502
New +$194K ﹤0.01% 998
2024
Q4 		– Sell
-8,788
Closed -$61.3K – 1605
2024
Q3 		$61.3K Sell
8,788
-320
-4% -$2.34K ﹤0.01% 1046
2024
Q2 		$68.9K Buy
+9,108
New +$91.9K ﹤0.01% 1028

Other funds holding NPCE

PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Mitsubishi UFJ Asset Management's NPCE Position: Q2 2026 in Review

Mitsubishi UFJ Asset Management increased its Neuropace (NPCE) stake by 27% in Q2 2026, buying an estimated $33.8K and bringing the position to 9,890 shares worth $157K. The position accounts for ﹤0.01% of the portfolio, ranked #1049.

Mitsubishi UFJ Asset Management first reported a position in NPCE in Q2 2024 and has held it in 7 quarters since. The position peaked at $173K in Q2 2025. 113 funds tracked by Wall St. Rank hold NPCE as of Q2 2026.

  • Mitsubishi UFJ Asset Management held 9,890 shares of Neuropace worth $157K as of Q2 2026.
  • Mitsubishi UFJ Asset Management bought 2,100 Neuropace shares in Q2 2026, an estimated $33.8K.
  • Neuropace made up ﹤0.01% of Mitsubishi UFJ Asset Management's portfolio in Q2 2026, its #1049 holding.
  • Mitsubishi UFJ Asset Management first reported a position in Neuropace in Q2 2024 and has held it in 7 quarters since.
  • Mitsubishi UFJ Asset Management's Neuropace position peaked at $173K in Q2 2025.
  • 113 funds tracked by Wall St. Rank held Neuropace as of Q2 2026.

Based on Mitsubishi UFJ Asset Management's 13F filing for Q2 2026, filed 7 Aug 2026.